Allspring Global Investments
HGEN

Allspring Global Investments’s HUMANIGEN, INC. HGEN Stock Holding History

Allspring Global Investments’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,038
Closed -$6K – 3031
2022
Q1 		$6K Buy
+2,038
New +$5.45K ﹤0.01% 2979

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments's HGEN Position: Q2 2022 in Review

Allspring Global Investments sold out of HUMANIGEN, INC. (HGEN) in Q2 2022, closing a stake of 2,038 shares — an estimated $6K sold.

Allspring Global Investments first reported a position in HGEN in Q1 2022 and held it in 1 quarter. The position peaked at $6K in Q1 2022. 65 funds tracked by Wall St. Rank hold HGEN as of Q2 2022.

  • Allspring Global Investments reported no remaining HUMANIGEN, INC. position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 2,038 HUMANIGEN, INC. shares in Q2 2022, an estimated $6K.
  • Allspring Global Investments first reported a position in HUMANIGEN, INC. in Q1 2022 and held it in 1 quarter.
  • Allspring Global Investments's HUMANIGEN, INC. position peaked at $6K in Q1 2022.
  • 65 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.